Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes

Author(s):
Dussen, L. van; Cox, T.M.; Hendriks, E.J.; Morris, E.; Akkerman, E.M.; Maas, M.; Groener, J.E.M.; Aerts, J.M.F.G. (0000-0001-8168-2565); Deegan, P.B.; Hollak, C.E.M.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012
Language
English
Is part of
Haematologica (2012), Vol. 87, p. 1850-1854
hdl
1887/61411
doi
10.3324/haematol.2011.059071